Caraco drugs seized at Michigan facilities by US Marshals
This article was originally published in Scrip
Executive Summary
US Marshals, at the request of the US FDA, have seized all generic medicines and raw ingredients on the premises of Caraco at three Michigan plants, citing the firm's inability to take appropriate steps to correct violations of current good manufacturing practice (cGMP).